Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Istradefylline adjustment of levodopa in Parkinson's disease
jRCTs031180248Completed
- Sponsor
- Kyowa Kirin
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of Istradefylline and levodopa in Parkinson's disease (PD) (2 arms), sponsored by Kyowa Kirin. Primary endpoint: Accumulated dose of levodopa. Started May 2019; status: completed.
02
Drugs
Istradefyllinelevodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCTs031180248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180248.